ATON Trademark

Trademark Overview


On Friday, December 8, 2023, a trademark application was filed for ATON with the United States Patent and Trademark Office. The USPTO has given the ATON trademark a serial number of 79396488. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Thursday, January 30, 2025. This trademark is owned by HYBRIGENICS SA. The ATON trademark is filed in the Chemical Products, Pharmaceutical Products, and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical products for treating viral and infectious diseases, cancer, neurodegenerative diseases, obesity and diabetes; chemical pharmaceutical preparations for treating viral and infectious diseases, cancer, neurodegenerative diseases, obesity and diabetes; veterinary products for treating viral and infectious diseases, cancer, neurodegenerative diseases, obesity and diabetes; sanitary sterilizing preparations; chemical preparations for pharmaceutical use for treating viral and infectious diseases, cancer, neurodegenerative diseases, obesity and diabetes; chemical preparations for treating viral and infectious diseases, cancer, neurodegenerative diseases, obesity and diabetes for medical use; chemical preparations for treating viral and infectious diseases, cancer, neurodegenerative diseases, obesity and diabetes for veterinary use; pharmaceutical products for treating viral and infectious diseases, cancer, neurodegenerative diseases, obesity and diabetes; biological, biochemica...

Chemical products, namely, chemical additives, chemical active ingredients, chemical solvents, chemical reagents, chemical preservatives, chemical antioxidants, ethylene oxide, ethylene glycol, chlorine for use in the manufacture of pharmaceuticals; active chemical ingredients intended for the manufacture of medicines for treating viral and infectious diseases, cancer, neurodegenerative diseases, obesity and diabetes; biological preparations other than for medical or veterinary use; biological tissue cultures other than for medical or veterinary purposes; cultures of microorganisms other than for medical or veterinary use; stem cells other than for medical or veterinary use; protein being raw material for scientific and medical research; vitamins for manufacturing pharmaceutical products; chemical reagents other than for medical or veterinary use; diagnostic reagents for in-vitro use in biochemistry, clinical chemistry and microbiology other than for medical use; chemical reagents for ...

Scientific and industrial research and development of vaccines and medicines; engineering; product research and development in industrial processes; product research and development concerning the automation of industrial processes; surveying, namely, engineering work; biological research; medical research; chemical research; scientific laboratory services; laboratory services for medical research; scientific laboratory services for studies, research and analysis in the field of chemistry and biology; scientific and technological research relating to patent mapping; research and development in the field of antibodies; research and development in the field of microorganisms and cells; research and development in the field of biochemistry and biotechnology; information about scientific research in the field of biochemistry and biotechnology; technological consultancy services in the technology field of biotechnology and medical technologies; scientific research in the nature of conductin...
aton

General Information


Serial Number79396488
Word MarkATON
Filing DateFriday, December 8, 2023
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateThursday, January 30, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 18, 2025

Trademark Statements


Goods and ServicesPharmaceutical products for treating viral and infectious diseases, cancer, neurodegenerative diseases, obesity and diabetes; chemical pharmaceutical preparations for treating viral and infectious diseases, cancer, neurodegenerative diseases, obesity and diabetes; veterinary products for treating viral and infectious diseases, cancer, neurodegenerative diseases, obesity and diabetes; sanitary sterilizing preparations; chemical preparations for pharmaceutical use for treating viral and infectious diseases, cancer, neurodegenerative diseases, obesity and diabetes; chemical preparations for treating viral and infectious diseases, cancer, neurodegenerative diseases, obesity and diabetes for medical use; chemical preparations for treating viral and infectious diseases, cancer, neurodegenerative diseases, obesity and diabetes for veterinary use; pharmaceutical products for treating viral and infectious diseases, cancer, neurodegenerative diseases, obesity and diabetes; biological, biochemical and biotechnological preparations for treating viral and infectious diseases, cancer, neurodegenerative diseases, obesity and diabetes for medical use; medicines for treating viral and infectious diseases, cancer, neurodegenerative diseases, obesity and diabetes for human use, remedies for treating viral and infectious diseases, cancer, neurodegenerative diseases, obesity and diabetes for human use; medicines for treating viral and infectious diseases, cancer, neurodegenerative diseases, obesity and diabetes for veterinary use, remedies for treating viral and infectious diseases, cancer, neurodegenerative diseases, obesity and diabetes for veterinary use; stem cells for medical use; stem cells for veterinary use; biological tissue cultures for medical use; biological tissue cultures for veterinary use; cultures of micro-organisms for medical use; skin grafts being living tissues; surgical implants made of living tissue; antibodies; diagnostic preparations for medical use; diagnostic preparations for veterinary use; in-vitro diagnostic preparations for medical use; biotechnological preparations for treating viral and infectious diseases, cancer, neurodegenerative diseases, obesity and diabetes for medical use; chemical reagents for medical and veterinary use; diagnostic biomarking reagents for medical use; antibiotics
Goods and ServicesChemical products, namely, chemical additives, chemical active ingredients, chemical solvents, chemical reagents, chemical preservatives, chemical antioxidants, ethylene oxide, ethylene glycol, chlorine for use in the manufacture of pharmaceuticals; active chemical ingredients intended for the manufacture of medicines for treating viral and infectious diseases, cancer, neurodegenerative diseases, obesity and diabetes; biological preparations other than for medical or veterinary use; biological tissue cultures other than for medical or veterinary purposes; cultures of microorganisms other than for medical or veterinary use; stem cells other than for medical or veterinary use; protein being raw material for scientific and medical research; vitamins for manufacturing pharmaceutical products; chemical reagents other than for medical or veterinary use; diagnostic reagents for in-vitro use in biochemistry, clinical chemistry and microbiology other than for medical use; chemical reagents for developing monoclonal antibodies other than for medical or veterinary use; monoclonal antibodies for diagnostic use, namely, for scientific purposes other than medical; monoclonal antibodies for industrial scientific research use; chemical substances for analyses in laboratories, other than for medical or veterinary purposes intended for the biotechnology industry
Goods and ServicesScientific and industrial research and development of vaccines and medicines; engineering; product research and development in industrial processes; product research and development concerning the automation of industrial processes; surveying, namely, engineering work; biological research; medical research; chemical research; scientific laboratory services; laboratory services for medical research; scientific laboratory services for studies, research and analysis in the field of chemistry and biology; scientific and technological research relating to patent mapping; research and development in the field of antibodies; research and development in the field of microorganisms and cells; research and development in the field of biochemistry and biotechnology; information about scientific research in the field of biochemistry and biotechnology; technological consultancy services in the technology field of biotechnology and medical technologies; scientific research in the nature of conducting clinical trials for others; testing of materials; scientific and industrial research, fine tuning industrial processes, namely, troubleshooting of industrial process control computer software problems, data automation using proprietary software to evaluate, analyze and collect service data, professional scientific consultancy, material testing, scientific laboratory services, and computer programming, all these services being dedicated to biology, bioinformatics, biochemistry, biotechnology, pharmacy, proteomics, genomics, cosmetics and agronomy; industrial and scientific research services in the field of molecular biology and more specifically genomics, proteomics, protein screening and protein interaction research; scientific research and analysis in the field of genetics and genetic engineering and in the field of chemical reagents; research and development of new products for third parties; development and maintenance of computer platforms in the field of the pharmaceutical industry and biotechnology; computer platform as a service [PaaS] featuring software for scientific analysis and research in the field of the pharmaceutical industry and biotechnology; software engineering services for data processing in the field of the pharmaceutical industry and biotechnology; computer programming services for data processing in the field of the pharmaceutical industry and biotechnology; developing and hosting databases in the field of the pharmaceutical industry and biotechnology; scientific data analysis in the field of the pharmaceutical industry and biotechnology; electronic storage of data in the field of the pharmaceutical industry and biotechnology; engineering services for developing computer data banks in the field of the pharmaceutical industry and biotechnology; developing and providing online non-downloadable computer software platforms for scientific analysis and research and antibody data bank, namely, data warehousing

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateThursday, May 30, 2024
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, May 30, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, May 30, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameHYBRIGENICS SA
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressFR

Trademark Events


Event DateEvent Description
Thursday, May 30, 2024SN ASSIGNED FOR SECT 66A APPL FROM IB
Saturday, June 1, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, July 9, 2024ASSIGNED TO EXAMINER
Thursday, July 11, 2024NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, August 2, 2024NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Saturday, June 1, 2024APPLICATION FILING RECEIPT MAILED
Wednesday, July 10, 2024NON-FINAL ACTION WRITTEN
Friday, August 2, 2024REFUSAL PROCESSED BY MPU
Sunday, August 25, 2024REFUSAL PROCESSED BY IB
Monday, January 27, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, January 27, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, January 27, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, January 27, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, January 27, 2025TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Monday, January 27, 2025TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, January 27, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, January 27, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, January 27, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, January 29, 2025APPROVED FOR PUB - PRINCIPAL REGISTER